Breaking News

How cuts decimated the government's mental health and addiction agency

November 1, 2025

We're looking for your feedback: What do you like about this newsletter, what could we do better? Fill out this quick Weekend Reads survey, and you'll be entered for a chance to win a $100 promo code to the STAT merch store. Thanks for reading! — Sarah Mupo, director of editorial operations

Moderna has shrunk considerably, from pandemic-era revenues of $19.3 billion in 2022 to $3.2 billion last year.
Mike Reddy for STAT

STAT+ | How Moderna, the company that helped save the world, unraveled

An in-depth analysis of Moderna's dramatic rise and fall, from mRNA triumph to existential crisis, and what its uncertain future means for biotech.

By Jason Mast


Miriam Merad in her office at Mount Sinai.
Chantal Heijnen for STAT

STAT+ | Miriam Merad's 20-year quest to understand one cell is starting to rewrite the rules of cancer immunotherapy

After decades studying macrophages, Miriam Merad believes these overlooked immune cells could unlock a new frontier in cancer treatment.

By Angus Chen


Maria Fabrizio for STAT

STAT+ | Trump cuts have decimated the federal addiction and mental health agency

Trump administration cuts SAMHSA staff by half, terminates $2 billion in grants, during a drug overdose epidemic and a suicide crisis.

By O. Rose Broderick and Lev Facher



STAT+ | Opinion: All of a sudden, dementia treatment is becoming very exciting

Biomarker-based therapeutics and better diagnoses are changing dementia care in deeply meaningful ways for patients, families, and physicians.

By Jason Karlawish


STAT+ | Under Vinay Prasad, employees at a key FDA center fear speaking out, look for the exits

Prasad, the hired-fired-rehired head of the Center for Biologics Evaluation and Research, rattles FDA staff by expanding power, pushing out senior leaders.

By Lizzy Lawrence


STAT+ | Scientists had to change more than 700 grant titles to receive NIH funding. Health disparities researchers fear what's next

NIH denies having a banned words list but a new analysis finds hundreds of grant titles were changed to avoid terms like equity, disparity, and minority.

By Anil Oza


STAT+ | What do Rollerblades and Ozempic have in common?

Ozempic is sold for diabetes but has become synonymous with weight loss drugs. Will the trademark go the way of aspirin and dumpsters?

By Alex Hogan


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Weekend Reads? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments